Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

A new Hospital-Wide system aims to cut unplanned return surgeries in orthopaedics

NCT ID NCT07744633

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 04, 2026 · Last updated Aug 07, 2026 · Updated 3 times

Summary

This study tests a hospital-level closed-loop management system designed to improve how orthopaedic departments handle unplanned returns to the operating room. The system includes standardized definitions, non-punitive reporting, case review, and continuous quality improvement actions. Participating hospitals will implement the system, and researchers will measure reporting accuracy and management quality, as well as rates of unplanned returns and complications. The goal is to see if this organizational approach can enhance patient safety and surgical outcomes.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Closed-Loop Quality Improvement Programme for Unplanned Return to the Operating Room in Orthopaedics
What this could lead to
If effective, this system could reduce surgical complications and improve patient safety in orthopaedic departments across hospitals.
What could go wrong
This is a quality improvement study, not a clinical treatment trial, so it may not directly change patient outcomes. Success depends on hospital staff adherence and may not generalize to all settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 25 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Dec 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * A public secondary or tertiary general hospital or specialty hospital in China. * Has an independent orthopaedic ward and an established orthopaedic surgical team. * Has performed at least 2,000 orthopaedic surgical procedures per year during each of the previous three years. * Is willing to participate in the study and sign the study cooperation agreement. * The head of the orthopaedic department, or an authorized departmental representative, is willing to provide written informed consent on behalf of the participating department. * Has accessible hospital discharge records, surgical and anaesthesia information systems, and the information infrastructure required for data verification. * Is able to provide the required aggregated and de-identified study data and complete the scheduled follow-up assessments. Exclusion Criteria: * Is currently conducting a similar quality improvement programme that may affect the evaluation of the study intervention. * Is unable to complete the required follow-up assessments or data reporting. * Experiences or is expected to experience major institutional restructuring during the study period that may substantially affect implementation of the intervention. The unit of enrollment, intervention, and analysis is the participating hospital and its orthopaedic department. Individual patients are not recruited as research participants. Only aggregated and de-identified hospital-level data will be collected.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Closed-loop quality improvement programme are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.